General paperEffects of Efonidipine Hydrochloride (cas 111011-79-1) (NZ-105), a calcium antagonist, on renal function in conscious spontaneously hypertensive rats

Add time:08/23/2019    Source:sciencedirect.com

1.1. We investigated the effects of short- and long-term administration of Efonidipine Hydrochloride (cas 111011-79-1) (NZ-105), 1,4-dihydropyridine derivative, in conscious spontaneously hypertensive rats (SHR).2.2. Oral administration of NZ-105 for 12 weeks caused diuretic and natriuretic effects, which were not attenuated during the experimental period.3.3. In the short-term experiment for investigating the mechanism of the diuretic effect, intravenous injection of NZ-105 (0.03 mg/kg of body weight) significantly increased the urine volume (UV), renal plasma flow (RPF) and glomerular filtration rate (GFR). The increment rate of UV and RPF was 105.4 ± 17.8% and 111.7 ± 72.8%, respectively, which were larger than the increment rate of GFR (38.5 ± 14.0%).4.4. The diuretic or natriuretic effect of NZ-105 was suggested to be due to both the inhibition of sodium reabsorption and, at least in part, the increase of GFR.

We also recommend Trading Suppliers and Manufacturers of Efonidipine Hydrochloride (cas 111011-79-1). Pls Click Website Link as below: cas 111011-79-1 suppliers

Prev:General PapersEffects of the Antihypertensive Drug Efonidipine Hydrochloride (cas 111011-79-1) on Albuminuria and Renal Histopathology in Young Spontaneously Hypertensive Rats with Diabetes
Next:General paperRenal protective effect of Efonidipine Hydrochloride (cas 111011-79-1) (NZ-105), a new calcium antagonist, in spontaneously hypertensive rats)